Blood Screening for HBV DNA

Journal of Clinical Virology

Volumn 36, Issue SUPPL. 1, 2006, Pages

  Fang, Chyang T ^a  

^a Biomedical Research and Development   (United States)

Author keywords

anti HBc; Blood safety; HBsAg; HBV DNA; NAT

Indexed keywords

VIRUS DNA;

ARTICLE; BLOOD DONOR; BLOOD EXAMINATION; DNA DETERMINATION; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; NUCLEIC ACID AMPLIFICATION; PRIORITY JOURNAL; SEROLOGY;

BLOOD DONORS; DNA, VIRAL; HEPATITIS B VIRUS; HUMANS; MASS SCREENING; NUCLEIC ACID AMPLIFICATION TECHNIQUES;

EID: 33745895001     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(06)80006-5     Document Type: Article

References (20)

1. Allain J. Occult hepatitis B virus infection: implications in transfusion. Vox Sang 86 (2004) 83-91
2. Biswas R., Tabor E., Hsia C., et al. Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection. Transfusion 43 (2003) 788-798
3. Busch M. HBV viremia preceding HBsAg positivity: implications for MP and ID HBV NAT. Presented at the US FDA Blood Products Advisory Committee meeting. Gaithersburg, MD (March 15, 2001)
4. (Suppl). De Felice C., Morelli F., Perna E., et al. Hepatitis B residual risk in transfusion. Vox Sang 89 (2005) 82
5. Dodd R., Notari I., and Stramer S. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion 42 (2002) 975-979
6. Jackson B., Busch M., Stramer S., and AuBuchon J. The cost-effectiveness of NAT for HIV, HCV and HBV in whole-blood donations. Transfusion 43 (2003) 721-729
7. Kleinman S., and Busch M. Hepatitis B virus amplified and back in the blood safety spotlight. Transfusion 41 (2001) 1081-1085
8. Kleinman S., Strong D., Tegtmeier G., et al. Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test. Transfusion 45 (2005) 1247-1257
9. Koppelman M., Assal A., Chudy M., et al. Multicenter performance evaluation of a transcription-mediated amplification assay for screening of human immunodeficiency virus-1 RNA, hepatitis C virus RNA and hepatitis B virus DNA in blood donation. Transfusion 45 (2005) 1258-1266
10. Marshall D., Kleinman S., Wong J., et al. Cost-effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States. Vox Sang 86 (2004) 28-40
11. [Epub ahead of print]. McCormick M., Dockter J., Linnen J., Kolk D., Wu Y., and Giachetti C. Evaluation of a new molecular assay for detection of human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA. J Clin Virol (2006 Jan 19)
12. Mimms L. Window period detection of HBV with the Procleix Ultrio assay. Presented at the US FDA Blood Products Advisory Committee meeting. Galthersburg, MD (July 21, 2005)
13. Roth W., Weber M., Petersen D., et al. NAT for HBV and anti-HBc testing increase blood safety. Transfusion 42 (2002) 869-875
14. (Suppl). Satake S., Taira R., Yugi H., et al. Lookback study for transfusion-related HBV infection in Japan. Transfusion 45 (2005) 9A-10A
15. Schreiber G., Busch M., Kleinman S., et al. The risk of transfusion-transmitted viral infections. N Engl J Med 334 (1996) 1685-1690
16. Stramer SL, Brodsky JP, Preston, SB, et al. Comparative sensitivity of HBsAg and HBV NAT. Transfusion 2001; 41(Suppl):8S.
17. Stramer S., Glynn S., Kleinman S., et al. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N Engl J Med 351 (2004) 760-768
18. Stramer S., Fang C., Foster G., et al. West Nile virus among blood donors in the United States, 2003 and 2004. N Engl J Med 353 (2005) 451-459
19. Stramer S. Pooled hepatitis B virus DNA testing by nucleic acid amplification: implementation or not. Transfusion 45 (2005) 1242-1246
20. Yoshikawa A., Gotanda Y., Itabashi M., et al. Hepatitis B NAT viruspositive blood donors in the early and late stages of HBV infections: analyses of the window period and kinetics of HBV DNA. Vox Sang 88 (2005) 77-86